Cargando…
LINC-41. TREATMENT OF RECURRENT MEDULLOBLASTOMA IN CHILDREN IN LOW INCOME SETTINGS
INTRODUCTION: Children with recurrent medulloblastoma after initial therapy have very poor prognosis due to limited second line treatment options and significant treatment-related morbidity. METHODS: A retrospective chart review of 18 children with recurrent or progressive medulloblastoma, treated i...
Autores principales: | Kizyma, Roman, Zapotochna, Khrystyna, Romanyshyn, Bogdan, Kizyma, Zoryana, Sobko, Roman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715819/ http://dx.doi.org/10.1093/neuonc/noaa222.474 |
Ejemplares similares
-
LINC-31. TREATMENT OUTCOME IN CHILDREN WITH MEDULLOBLASTOMA IN MEDIUM-INCOME COUNTRY: AN EXPERIENCE FROM A SINGLE TERTIARY CENTRE IN KUALA LUMPUR, MALAYSIA
por: Loh, C-Khai, et al.
Publicado: (2020) -
LINC-16. MEDULLOBLASTOMA IN A BOY WITH RUBINSTEIN-TAYBI SYNDROME: A CASE REPORT
por: del Campo, Regina M Navarro-Martin, et al.
Publicado: (2020) -
LINC-15. OUTCOME OF CHINESE CHILDREN WITH MEDULLOBLASTOMA: A MULTI-CENTER EXPERIENCE WITH RISK-ADAPTED THERAPY
por: Sun, Xiaofei, et al.
Publicado: (2020) -
LINC-30. A CLINICOPATHOLOGICAL STUDY OF IMMUNOGENICITY AND IMMUNE EVASION MECHANISMS AMONG MOLECULAR SUBGROUPS OF MEDULLOBLASTOMA
por: Kaur, Kavneet, et al.
Publicado: (2020) -
LINC-11. Intrathecal methotrexate in a young child with medulloblastoma with extensive nodularity. An alternative to intra-ventricular route in Low and Middle Income Countries?
por: Leal-Cavazos, Carlos, et al.
Publicado: (2022)